Walleye Trading
BMY icon

Walleye Trading’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.3M Sell
1,571,400
-221,800
-12% -$12.9M 0.16% 124
2025
Q4 		$96.7M Buy
1,793,200
+520,400
+41% +$25M 0.14% 154
2025
Q3 		$57.4M Buy
1,272,800
+396,600
+45% +$18.5M 0.09% 220
2025
Q2 		$40.6M Sell
876,200
-662,000
-43% -$32.5M 0.07% 279
2025
Q1 		$93.8M Buy
1,538,200
+553,300
+56% +$32.3M 0.22% 75
2024
Q4 		$55.7M Buy
984,900
+503,300
+105% +$28.1M 0.12% 176
2024
Q3 		$24.9M Buy
481,600
+209,500
+77% +$9.83M 0.05% 379
2024
Q2 		$11.3M Buy
272,100
+38,000
+16% +$1.7M 0.03% 622
2024
Q1 		$12.7M Sell
234,100
-92,400
-28% -$4.71M 0.03% 600
2023
Q4 		$16.8M Buy
326,500
+41,600
+15% +$2.18M 0.04% 531
2023
Q3 		$16.5M Sell
284,900
-72,800
-20% -$4.46M 0.04% 441
2023
Q2 		$22.9M Buy
357,700
+81,600
+30% +$5.47M 0.07% 262
2023
Q1 		$19.1M Buy
276,100
+5,700
+2% +$402K 0.04% 401
2022
Q4 		$19.5M Sell
270,400
-61,900
-19% -$4.67M 0.06% 369
2022
Q3 		$23.6M Sell
332,300
-15,100
-4% -$1.1M 0.07% 270
2022
Q2 		$26.8M Sell
347,400
-94,400
-21% -$7.19M 0.09% 232
2022
Q1 		$32.3M Buy
441,800
+268,200
+154% +$18M 0.1% 201
2021
Q4 		$10.8M Sell
173,600
-38,900
-18% -$2.28M 0.04% 557
2021
Q3 		$12.6M Buy
212,500
+2,600
+1% +$171K 0.05% 454
2021
Q2 		$14M Buy
209,900
+160,800
+327% +$10.5M 0.05% 318
2021
Q1 		$3.1M Sell
49,100
-140,500
-74% -$8.74M 0.01% 985
2020
Q4 		$11.8M Sell
189,600
-366,900
-66% -$22.6M 0.05% 341
2020
Q3 		$33.6M Buy
556,500
+232,500
+72% +$14M 0.18% 64
2020
Q2 		$19.1M Sell
324,000
-7,600
-2% -$455K 0.12% 125
2020
Q1 		$18.5M Sell
331,600
-54,500
-14% -$3.33M 0.14% 75
2019
Q4 		$24.8M Sell
386,100
-16,700
-4% -$956K 0.17% 93
2019
Q3 		$20.4M Sell
402,800
-10,000
-2% -$470K 0.17% 72
2019
Q2 		$18.7M Sell
412,800
-2,300,500
-85% -$107M 0.16% 89
2019
Q1 		$129M Buy
2,713,300
+2,605,600
+2,419% +$130M 1.01% 6
2018
Q4 		$5.6M Sell
107,700
-34,500
-24% -$1.85M 0.04% 426
2018
Q3 		$8.83M Buy
142,200
+82,400
+138% +$4.89M 0.05% 382
2018
Q2 		$3.31M Buy
59,800
+35,100
+142% +$1.9M 0.02% 897
2018
Q1 		$1.56M Sell
24,700
-39,700
-62% -$2.55M 0.01% 1468
2017
Q4 		$3.95K Sell
64,400
-19,000
-23% -$1.19M 0.02% 810
2017
Q3 		$5.32K Sell
83,400
-54,200
-39% -$3.16M 0.03% 623
2017
Q2 		$7.67K Sell
137,600
-249,300
-64% -$13.6M 0.05% 394
2017
Q1 		$21K Buy
386,900
+184,100
+91% +$10.1M 0.15% 81
2016
Q4 		$11.9M Buy
202,800
+40,600
+25% +$2.22M 0.08% 154
2016
Q3 		$8.74M Buy
162,200
+115,800
+250% +$7.44M 0.06% 222
2016
Q2 		$3.41M Sell
46,400
-84,500
-65% -$5.97M 0.02% 670
2016
Q1 		$8.36M Buy
130,900
+34,900
+36% +$2.2M 0.07% 244
2015
Q4 		$6.61M Buy
96,000
+81,900
+581% +$5.41M 0.06% 295
2015
Q3 		$837K Sell
14,100
-15,300
-52% -$971K 0.01% 1193
2015
Q2 		$1.96M Buy
29,400
+10,700
+57% +$705K 0.02% 712
2015
Q1 		$1.2M Buy
18,700
+3,300
+21% +$207K 0.01% 914
2014
Q4 		$910K Sell
15,400
-48,300
-76% -$2.72M 0.01% 1109
2014
Q3 		$3.26M Sell
63,700
-28,000
-31% -$1.4M 0.04% 251
2014
Q2 		$4.45K Buy
91,700
+73,900
+415% +$3.64M 0.06% 157
2014
Q1 		$926 Buy
17,800
+7,000
+65% +$372K 0.01% 903
2013
Q4 		$575K Sell
10,800
-83,600
-89% -$4.26M 0.01% 1472
2013
Q3 		$4.37M Buy
94,400
+23,900
+34% +$1.05M 0.05% 302
2013
Q2 		$3.15M Buy
+70,500
New +$3.06M 0.03% 426

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's BMY Position: Q4 2025 in Review

Walleye Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 535,133 shares — an estimated $25.7M sold.

Walleye Trading first reported a position in BMY in Q2 2013 and held it in 36 quarters. The position peaked at $49.3M in Q3 2024. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Walleye Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 535,133 Bristol-Myers Squibb shares in Q4 2025, an estimated $25.7M.
  • Walleye Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 36 quarters.
  • Walleye Trading's Bristol-Myers Squibb position peaked at $49.3M in Q3 2024.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.